CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 122 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,618,748 | +105.7% | 54,430 | +24.6% | 0.00% | – |
Q2 2023 | $787,005 | +20.9% | 43,674 | +7.8% | 0.00% | – |
Q1 2023 | $651,000 | +102258.5% | 40,513 | +16.8% | 0.00% | – |
Q4 2022 | $636 | -99.9% | 34,694 | +6.1% | 0.00% | – |
Q3 2022 | $642,000 | +11.5% | 32,690 | +5.8% | 0.00% | – |
Q2 2022 | $576,000 | -67.9% | 30,889 | -62.2% | 0.00% | – |
Q1 2022 | $1,793,000 | +30.7% | 81,736 | +69.3% | 0.00% | – |
Q4 2021 | $1,372,000 | +182.3% | 48,273 | +109.3% | 0.00% | – |
Q3 2021 | $486,000 | +28.2% | 23,060 | +14.5% | 0.00% | – |
Q2 2021 | $379,000 | -63.1% | 20,141 | -70.0% | 0.00% | – |
Q1 2021 | $1,026,000 | -7.9% | 67,104 | -15.1% | 0.00% | – |
Q4 2020 | $1,114,000 | +632.9% | 79,008 | +683.3% | 0.00% | – |
Q3 2020 | $152,000 | -5.0% | 10,087 | +10.4% | 0.00% | – |
Q2 2020 | $160,000 | +201.9% | 9,135 | +150.1% | 0.00% | – |
Q1 2020 | $53,000 | -44.2% | 3,653 | -2.8% | 0.00% | – |
Q4 2019 | $95,000 | +69.6% | 3,759 | +0.6% | 0.00% | – |
Q3 2019 | $56,000 | -25.3% | 3,737 | +23.2% | 0.00% | – |
Q2 2019 | $75,000 | +56.2% | 3,033 | +45.3% | 0.00% | – |
Q1 2019 | $48,000 | -9.4% | 2,087 | +17.2% | 0.00% | – |
Q4 2018 | $53,000 | +15.2% | 1,780 | +10.4% | 0.00% | – |
Q3 2018 | $46,000 | – | 1,613 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Saturn V Capital Management LP | 623,819 | $11,336,501 | 9.41% |
Finepoint Capital LP | 822,745 | $15,056 | 4.87% |
Bain Capital Life Sciences Investors, LLC | 2,305,558 | $42,192 | 4.72% |
Opaleye Management Inc. | 732,000 | $13,395,600 | 4.66% |
5AM Venture Management, LLC | 862,286 | $15,779,834 | 4.24% |
SPHERA FUNDS MANAGEMENT LTD. | 671,644 | $12,291,085 | 2.64% |
First Light Asset Management, LLC | 1,329,313 | $24,326,428 | 2.26% |
BRAIDWELL LP | 3,469,674 | $63,495,034 | 2.13% |
BVF INC/IL | 2,736,613 | $50,080,018 | 2.11% |
Perceptive Advisors | 4,039,276 | $73,918,751 | 2.08% |